 Serum Amyloid P-Component
"Serum Amyloid P-Component" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Amyloid P component is a small, non-fibrillar glycoprotein found in normal serum and in all amyloid deposits. It has a pentagonal (pentaxin) structure. It is an acute phase protein, modulates immunologic responses, inhibits ELASTASE, and has been suggested as an indicator of LIVER DISEASE.
| Descriptor ID |
D000683
|
| MeSH Number(s) |
D12.776.049.407.875 D12.776.124.050.730 D12.776.395.690
|
| Concept/Terms |
Serum Amyloid P-Component- Serum Amyloid P-Component
- Amyloid P-Component, Serum
- P-Component, Serum Amyloid
- Serum Amyloid P Component
- Amyloid P Component
- P Component, Amyloid
|
Below are MeSH descriptors whose meaning is more general than "Serum Amyloid P-Component".
Below are MeSH descriptors whose meaning is more specific than "Serum Amyloid P-Component".
This graph shows the total number of publications written about "Serum Amyloid P-Component" by people in this website by year, and whether "Serum Amyloid P-Component" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 | | 2011 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Serum Amyloid P-Component" by people in Profiles.
-
Rutemark C, Alicot E, Bergman A, Ma M, Getahun A, Ellmerich S, Carroll MC, Heyman B. Requirement for complement in antibody responses is not explained by the classic pathway activator IgM. Proc Natl Acad Sci U S A. 2011 Oct 25; 108(43):E934-42.
-
Kanbay M, Ikizek M, Solak Y, Selcoki Y, Uysal S, Armutcu F, Eryonucu B, Covic A, Johnson RJ. Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease. Am J Nephrol. 2011; 33(4):325-31.
-
Holers VM. Phenotypes of complement knockouts. Immunopharmacology. 2000 Aug; 49(1-2):125-31.
-
Caspi D, Zalzman S, Baratz M, Teitelbaum Z, Yaron M, Pras M, Baltz ML, Pepys MB. Imaging of experimental amyloidosis with 131I-labeled serum amyloid P component. Arthritis Rheum. 1987 Nov; 30(11):1303-6.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|